CRISPR Gene Editing Makes Prostate Cancer Visible to Immunotherapy

Prostate cancer patients currently lack effective treatment options; this research offers potential therapeutic benefit for affected populations.

For decades, prostate cancer has persisted not merely because it is aggressive, but because it is invisible — cloaking itself from the very immune system designed to destroy it. Researchers have now used CRISPR gene editing to uncover the precise mechanism of this concealment and, crucially, to reverse it. By restoring the molecular signals that mark cancer cells as threats, scientists may have found a way to make immunotherapy — long ineffective against prostate cancer — finally see its target. The discovery reframes the disease not as an unconquerable force, but as one that has simply been h

CRISPR Gene Editing Makes Prostate Cancer Visible to Immunotherapy

Cobertura Relacionada

Receba o Register no seu e-mail